Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
Go back to Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion| (NASDAQ: CVKD) | Delayed: 2.16 -0.17 (7.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.33 | 52 Week High | $ | |||
| Open | $2.30 | 52 Week Low | $ | |||
| Day High | $2.36 | P/E | N/A | |||
| Day Low | $2.13 | EPS | $ | |||
| Volume | 46,569 | |||||

